Lifastuzumab (Anti-SLC34A2), 1mg*25

Lifastuzumab (Anti-SLC34A2), 1mg*25

Upifitamab (Anti-SLC34A2), 1mg*5

Upifitamab (Anti-SLC34A2), 1mg*5

Upifitamab (Anti-SLC34A2), 1mg

3.255,84 RON
SKU
SKM_A2351_1mg

Upifitamab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. Upifitamab can be used to synthesize an ADC compound, Upifitamab rilsodotin, used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer. MW : 145.5 KD.

Mai multe informatii
Price 2.736,00 RON (preturile sunt fara TVA)
Description

Upifitamab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. Upifitamab can be used to synthesize an ADC compound, Upifitamab rilsodotin, used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer. MW : 145.5 KD.